Merck (BSP:MRCK34) Ending Cash Position : R$28,240 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Merck Ending Cash Position?

Merck's Ending Cash Position for the quarter that ended in Mar. 2024 was R$28,240 Mil.

Merck's quarterly Ending Cash Position declined from Sep. 2023 (R$42,814 Mil) to Dec. 2023 (R$33,853 Mil) and declined from Dec. 2023 (R$33,853 Mil) to Mar. 2024 (R$28,240 Mil).

Merck's annual Ending Cash Position increased from Dec. 2021 (R$46,184 Mil) to Dec. 2022 (R$66,999 Mil) but then declined from Dec. 2022 (R$66,999 Mil) to Dec. 2023 (R$33,853 Mil).

Merck Ending Cash Position Historical Data

The historical data trend for Merck's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Ending Cash Position Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

40,774.10

41,944.74

46,183.57

66,999.49

33,852.72

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															50,971.36	27,724.33	42,813.59	33,852.72	28,240.45

Merck Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Merck's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	62585.145	+	-28732.427
	=	33,853

Merck's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	34405.438	+	-6164.992
	=	28,240

Merck Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Merck's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BSP:MRCK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BSP:MRCK34) Headlines

No Headlines